Journal Club E38: EMPA-KIDNEY: Empagliflozin Works for Kidney Disease Even Without Diabetes

from AZense Journal Club · host Azense Medical Education

Does empagliflozin reduce CKD progression in a broad population including non-diabetic patients?

Episode metadata supplied by the publisher feed · Published Dec 22, 2025

Embed this episode

Attribution link and audio player

Ready to play

Journal Club E38: EMPA-KIDNEY: Empagliflozin Works for Kidney Disease Even Without Diabetes

0:00 7:00

1×

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

Similar Episodes

No similar episodes found.

No similar podcasts found.

This episode is 7 minutes long.

This episode was published on December 22, 2025.

Yes. Use the download control on the episode player to save the publisher-provided media file.

URL copied to clipboard!